294 related articles for article (PubMed ID: 29685144)
1. Emerging roles of epithelial-mesenchymal transition in hematological malignancies.
Chen SC; Liao TT; Yang MH
J Biomed Sci; 2018 Apr; 25(1):37. PubMed ID: 29685144
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. An "unexpected" role for EMT transcription factors in hematological development and malignancy.
Radhakrishnan K; Truong L; Carmichael CL
Front Immunol; 2023; 14():1207360. PubMed ID: 37600794
[TBL] [Abstract][Full Text] [Related]
4. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
5. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
6. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.
Kucuksayan H; Akca H
Tumour Biol; 2017 Sep; 39(9):1010428317706212. PubMed ID: 28937318
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
8. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.
Bogachek MV; De Andrade JP; Weigel RJ
Cancer Res; 2015 Jan; 75(1):11-5. PubMed ID: 25524900
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy.
Chou YS; Yang MH
J Chin Med Assoc; 2015 Aug; 78(8):438-45. PubMed ID: 26078096
[TBL] [Abstract][Full Text] [Related]
10. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
11. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma.
Nagaishi M; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Giangaspero F; Ohgaki H
Brain Pathol; 2012 Sep; 22(5):670-6. PubMed ID: 22288519
[TBL] [Abstract][Full Text] [Related]
14. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.
Nieto MA; Cano A
Semin Cancer Biol; 2012 Oct; 22(5-6):361-8. PubMed ID: 22613485
[TBL] [Abstract][Full Text] [Related]
15. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.
Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H
BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801
[TBL] [Abstract][Full Text] [Related]
16. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.
Kolesnikoff N; Attema JL; Roslan S; Bert AG; Schwarz QP; Gregory PA; Goodall GJ
J Biol Chem; 2014 Apr; 289(16):11194-11205. PubMed ID: 24627491
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
19. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
Cervantes-Arias A; Pang LY; Argyle DJ
Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
